Skip to main content

Table 1 Characteristics of the analysis data set used for statistical modeling

From: Modeling of atrophy size trajectories: variable transformation, prediction and age-of-onset estimation

 

Count

Percent

Patients (n)

101

 

Eyes (N)

150

 

Bilateral GA

49

48.50%

Unilateral GA

52

51.50%

Hypertension

  

yes

56

55.40%

no

44

38.60%

Hypercholesterolemia

  

yes

28

27.70%

no

70

69.30%

No. of patients with no. of visits

  

2 visits

25

24.75%

3 visits

23

22.78%

4 visits

23

22.78%

5-9 visits

30

29.70%

 

Mean (Range)

Median (IQR)

Age at baseline

75.61

75.66

[years]

(57.23 - 95.06)

(70.67 - 80.62)

Follow-up time

3.36

2.90

[years]

(0.50 - 13.70)

(1.61 - 4.57)

GA size at baseline

5.64

4.30

mm2

(0.07 - 31.40)

(1.76 - 7.60)

  1. All data considered in this paper was collected from patients with GA secondary to AMD that were recruited for the FAM study. If further monitoring of these patients was performed via the DSGA study, the further progression is included in the analysis data set